Thunderful Group: Thunderful Group: Q4 2024 preview (Redeye)

Inission: Inission - Demand stabilisation in sight (ABG Sundal Collier)

OrganoClick: OrganoClick - Weaker Q4 likely, but set up for a stronger H1 (ABG Sundal Collier)

AVTECH Sweden: AVTECH Q4 2024: Clears turbulence, lands stellar preliminary results (Redeye)

Nexam Chemical Holding: Nexam Chemical - Fighting hard against PET-foam headwinds (ABG Sundal Collier)

Berner Industrier: Berner Industrier - Industrial recovery pushed forward (ABG Sundal Collier)

INVISIO: Invisio: Very strong Q4 and positive message for 2025 (Redeye)

Essity: 10 estimat inför Essitys rapport (Pinpoint Estimates)

Sandvik: 15 estimat inför Sandviks rapport (Pinpoint Estimates)

Metacon: Metacon: Clarifying the net liquidity calculation from our latest research update (Inderes)

Elicera Therapeutics: Elicera Therapeutics: Promising first data from CARMA study (Redeye)

Føroya Banki: Another guidance upgrade (Nordea)

Transtema Group: Transtema: Cautiously optimistic as we look into 2025 – Q4 preview (Carnegie)

Revenio Group: Revenio Extensive Report: The future looks bright (Inderes)

Stockpicker: Ework Group – Positivt trendbrott i orderingången (Stockpicker)

Norsk Titanium: Norsk Titanium: Closing the first year with meaningful revenue – H2(24) preview (Carnegie)

Curasight: Curasight (One-pager): Extensive pipeline milestones in 2025 (HC Andersen Capital via Inderes)

Ependion: 40 estimat inför Ependions rapport (Pinpoint Estimates)

PolarCool: Polarcool: Genombrott på horisonten - Mangold Insight Analys (Mangold Insight)

Green Landscaping Group: 16 estimat inför Green Landscapings rapport (Pinpoint Estimates)

Avanza Bank Holding: Avanza Bank Holdings resultat över förväntningarna (Pinpoint Estimates)

Nelly Group: Nelly: Dressed for success - SEB (SEB Research)

Seafire: Seafire: Domestic exposure to support 2025 recovery - SEB (SEB Research)

Alcadon Group: Alcadon: New CEO brings a useful toolbox - SEB (SEB Research)

Eolus Vind: Eolus: Capitalising on the US market – Q4(24) preview (Carnegie)

Vertiseit: Vertiseit: All focus on the integration of Visual Art - Q4 preview (Carnegie)

SinterCast: SinterCast - Triple headwinds in Q4, but recovery in '25 (ABG Sundal Collier)

Taaleri: Taaleri Extensive Report: Capital allocation matters a lot (Inderes)

CoinShares International: CoinShares - Estimates raised on crypto rally (ABG Sundal Collier)

Implantica: Analyst Group intervjuar Implanticas VD Peter Forsell (Analyst Group)

Xoma: Xoma: Investeringsunderlag - Kalqyl (Kalqyl)

BioInvent International: BioInvent: Presents on Redeye’s Fight Cancer Event (Redeye)

Lytix Biopharma: Lytix: Presents on Redeye’s Fight Cancer Event (Redeye)

Medivir: Medivir: Presents on Redeye’s Fight Cancer Event (Redeye)

Biovica International: Biovica: Presents on Redeye’s Fight Cancer Event (Redeye)

Elicera Therapeutics: Elicera: Presents on Redeye’s Fight Cancer Event (Redeye)

Mendus: Mendus: Presents on Redeye’s Fight Cancer Event (Redeye)

Ascelia Pharma: Ascelia: Presents on Redeye’s Fight Cancer Event (Redeye)

Oncopeptides: Oncopeptides: Presents on Redeye’s Fight Cancer Event (Redeye)

Annexin Pharmaceuticals: Annexin Pharmaceuticals: Presents on Redeye’s Fight Cancer Event (Redeye)